Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Rapid Assessment of Non-alcoholic Fatty Liver Disease (NAFLD) Using Magnetic Resonance Imaging With LiverMultiScan (RADIcAL1)

NCT03289897 is registered in ClinicalTrials.gov with Perspectum as lead sponsor.

NCT NCT03289897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03289897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Rapid Assessment of Non-alcoholic Fatty Liver Disease (NAFLD) Using Magnetic Resonance Imaging With LiverMultiScan (RADIcAL1)
Lead sponsor
Perspectum
Phase
Not applicable
Overall status
Completed
Start date
September 5, 2017
Completion date
December 31, 2020
Enrollment
801 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, nafld, nash - nonalcoholic steatohepatitis